Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis.

Anticancer research - 1 Jun 2023

Familiari Pietro, Lapolla Pierfrancesco, Picotti Veronica, Palmieri Mauro, Pesce Alessandro, Carosi Giulia, Relucenti Michela, Nottola Stefania, Gianno Francesca, Minasi Simone, Antonelli Manila, Frati Alessandro, Santoro Antonio, D'Andrea Giancarlo, Bruzzaniti Placido, LA Pira Biagia

Abstract excerpt

BACKGROUND/AIM: In the latest 2021 WHO classification of central nervous system tumours (CNS), gliomas that present isocitrate dehydrogenase (IDH) mutations are defined as diffuse low-grade gliomas (DLGGs). IDH mutations are commonly observed in this tumour type. The Extent of Resection (EOR) positively influence survival; however, it is still debated whether the predictive value of EOR is independent of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosome Aberrations

Share to Chromosomes, Human, Pair 1

Share to Chromosomes, Human, Pair 19

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Oligodendroglioma

Source

Identifiers

PMID: 37247932
DOI: 10.21873/anticanres.16432

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis.PMID 37247932Read ↗

[Oligodendroglioma, IDH Mutation and 1p/19q Codeletion].Semantic proximity Read ↗

Foundations of the Diagnosis and Management of Low-Grade Gliomas.Semantic proximity Read ↗

[Evolution of Glioma Diagnosis: The WHO 2021 Classification and Beyond].Semantic proximity Read ↗

Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System.Semantic proximity Read ↗

MRI Scoring Systems for Predicting Isocitrate Dehydrogenase Mutation and Chromosome 1p/19q Codeletion in Adult-type Diffuse Glioma Lacking Contrast Enhancement.Semantic proximity Read ↗

A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.Semantic proximity Read ↗

World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.Semantic proximity Read ↗

Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.Semantic proximity Read ↗

The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.Semantic proximity Read ↗

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.Semantic proximity Read ↗

RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.Semantic proximity Read ↗

Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.